Description 223Ra-Radium Dichloride (Xofigo), also known as Radium-223 dichloride, BAY88-8223, or Xofigo® (formerly 223Ra-Alpharadin), is a radioactive salt developed by Algeta ASA. It targets cancers that commonly metastasize to the bone. Unlike earlier radiotherapeutics, which were limited to pain palliation, 223Ra has demonstrated a significant improvement in overall survival (OS)… Continue Reading…